Wilhelm O, Hafter R, Graeff H
Frauenklinik der Technischen Universität München, F.R.G.
Thromb Res. 1987 Sep 15;47(6):673-81. doi: 10.1016/0049-3848(87)90106-x.
A method for the preparative isolation of high molecular weight fibrin degradation products (XDP) from ascitic fluid of patients with advanced ovarian cancer is described. By non-reduced and reduced PAA-Gel electrophoresis we could demonstrate that high molecular weight fibrin derivatives exist as E-complexes. A similarity of the polypeptide chain composition from in vitro samples and ascitic fluid could be shown. Immunoadsorption with anti-albumin followed by Westernblotting with anti-fibrinogen-demonstrated the existence of XDP/albumin-associates in ascitic fluid.
描述了一种从晚期卵巢癌患者腹水中制备性分离高分子量纤维蛋白降解产物(XDP)的方法。通过非还原和还原聚丙烯酰胺凝胶电泳,我们可以证明高分子量纤维蛋白衍生物以E复合物的形式存在。可以显示体外样品和腹水的多肽链组成具有相似性。用抗白蛋白进行免疫吸附,然后用抗纤维蛋白原进行蛋白质印迹,证明腹水中存在XDP/白蛋白结合物。